Back to search
Non-infectious Intermediate Uveitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-infectious Intermediate Uveitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-infectious Intermediate Uveitis trials you may qualify forThe purpose of this Phase 1, first in uveitis open-label study is to assess the safety and tolerability of TRX-103 in patients with non infectious uveitis (NIU)…
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) no…